Healthcare entity

sa-mRNA

Technology

market-trends is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Arcturus Therapeutics, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Healthcare story that mention sa-mRNA, all published on March 2, 2026.

Last mentioned: Mar 2, 2026

RSS updates
Share

Entity pulse

Recent coverage · sa-mRNA

1 story
5 avg impact
0% positive
0% negative
  • 100% neutral

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about sa-mRNA

market-trends is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Arcturus Therapeutics, the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Healthcare story that mention sa-mRNA, all published on March 2, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 3 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering sa-mRNA. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Q4 Earnings Release

    Both companies scheduled to report full-year 2025 financial results.

  2. ARCT-032 Phase 1b

    Arcturus releases positive interim data for Cystic Fibrosis candidate.

  3. Kostaive Approval

    Japan's MHLW approves the first sa-mRNA COVID-19 vaccine.

Stories mentioning sa-mRNA 1

sa-mRNA is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.